We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

301 hedge funds and large institutions have $5.84B invested in Ionis Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 103 increasing their positions, 89 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 35

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

16% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 89

3% more funds holding

Funds holding: 293 → 301 (+8)

2.47% more ownership

Funds ownership: 90.11% → 92.58% (+2.5%)

3% more capital invested

Capital invested by funds: $5.68B → $5.84B (+$155M)

17% less call options, than puts

Call options by funds: $71.6M | Put options by funds: $86.1M

Holders
301
Holders Change
+8
Holders Change %
+2.73%
% of All Funds
7.5%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
46
Increased
103
Reduced
89
Closed
35
Calls
$71.6M
Puts
$86.1M
Net Calls
-$14.5M
Net Calls Change
-$9.35M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$47.9M
2
Deutsche Bank
Deutsche Bank
Germany
+$45.2M
3
Bank of America
Bank of America
North Carolina
+$27.6M
4
BB
BB Biotech
Switzerland
+$26.6M
5
FCM
Farallon Capital Management
California
+$23.6M

Top Sellers

1
WRF
Waddell & Reed Financial
Kansas
-$31.3M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$25.2M
3
ClearBridge Investments
ClearBridge Investments
New York
-$20.3M
4
Invesco
Invesco
Georgia
-$10.2M
5
AG
Artal Group
Luxembourg
-$6.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
26
Stifel Financial
Missouri
$31.1M +$703K +13,420 +2%
AGA
27
Altrinsic Global Advisors
Connecticut
$30.6M -$3.7M -70,633 -10%
Northern Trust
28
Northern Trust
Illinois
$30M -$1.59M -30,438 -5%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$27.3M +$600K +11,447 +2%
FCM
30
Farallon Capital Management
California
$22.8M +$23.6M +450,000 New
PP
31
PDT Partners
New York
$21.5M +$22.3M +424,910 New
SA
32
Sicart Associates
New York
$19.7M +$89K +1,700 +0.4%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$19.6M +$210K +4,000 +1%
Charles Schwab
34
Charles Schwab
California
$19.4M +$743K +14,184 +4%
Mitsubishi UFJ Trust & Banking
35
Mitsubishi UFJ Trust & Banking
Japan
$18.7M -$32K -610 -0.2%
TCIM
36
TIAA CREF Investment Management
New York
$17.1M -$1.38M -26,412 -7%
MFWM
37
Motley Fool Wealth Management
Virginia
$16.8M -$541K -10,322 -3%
CS
38
Credit Suisse
Switzerland
$16M +$1.93M +36,766 +13%
GAM
39
Gotham Asset Management
New York
$14.7M -$3.55M -67,849 -19%
RCAMU
40
Rothschild & Co Asset Management US
Connecticut
$14.3M +$1.44M +27,426 +11%
UBS AM
41
UBS AM
Illinois
$13.7M +$333K +6,357 +2%
BG
42
Bellevue Group
Switzerland
$13.5M +$2.16M +41,144 +18%
MFAM
43
Motley Fool Asset Management
Virginia
$13.1M – – –
VanEck Associates
44
VanEck Associates
New York
$13.1M +$971K +18,545 +8%
AIM
45
ARK Investment Management
Florida
$12.5M +$3.69M +70,472 +40%
EDRH
46
Edmond de Rothschild Holding
Switzerland
$12.2M – – –
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$11.3M +$189K +3,600 +2%
Swiss National Bank
48
Swiss National Bank
Switzerland
$10.5M +$283K +5,400 +3%
Aviva
49
Aviva
United Kingdom
$10.5M +$342K +6,526 +3%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$10.3M +$378K +7,210 +4%
1
2
3 4 5

IONS Hedge Fund Activity: Q3 2017 in Review

301 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q3 2017, worth a combined $5.84B — up 2.7% from $5.68B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IONS positions and 35 closed out — a net gain of 11 holders — while 103 added to existing stakes and 89 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $47.9M. The largest seller was Waddell & Reed Financial, cutting an estimated $31.3M.

  • 301 institutional investors held Ionis Pharmaceuticals (IONS) as of Q3 2017, up from 293 in Q2 2017.
  • Funds reported $5.84B of Ionis Pharmaceuticals stock for Q3 2017, up 2.7% quarter-over-quarter.
  • 46 funds opened new Ionis Pharmaceuticals positions in Q3 2017 and 35 closed out, a net change of +11 holders.
  • The largest Ionis Pharmaceuticals buyer in Q3 2017 was Wellington Management Group, an estimated $47.9M added.
  • The largest Ionis Pharmaceuticals seller in Q3 2017 was Waddell & Reed Financial, an estimated $31.3M sold.

Based on aggregated 13F filings for Q3 2017.